CD8A and neoplasm: Genetic ablation of STAT3 in T cells or CPT1A inhibitor treatment in obese tumor-bearing mice suppresses breast tumor progression by reducing FAO, increasing glycolysis, and enhancing CD8+ T-cell functions [74].